Pring Turner Capital Group’s Bristol-Myers Squibb BMY Stock Holding History

Pring Turner Capital Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,440	Closed	-$220K	–	63
2023 Q2	$220K	Hold	3,440	–	–	0.2%	59
2023 Q1	$238K	Hold	3,440	–	–	0.24%	55
2022 Q4	$248K	Buy	+3,440	New	+$259K	0.27%	51
2016 Q1	–	Sell	-38,677	Closed	-$2.66M	–	34
2015 Q4	$2.66M	Sell	38,677 -400	-1%	-$26.4K	4.36%	9
2015 Q3	$2.31M	Sell	39,077 -2,250	-5%	-$143K	3.33%	16
2015 Q2	$2.75M	Sell	41,327 -683	-2%	-$45K	2.97%	19
2015 Q1	$2.71M	Sell	42,010 -2,755	-6%	-$172K	3.01%	20
2014 Q4	$2.64M	Sell	44,765 -550	-1%	-$31K	2.77%	22
2014 Q3	$2.32M	Sell	45,315 -350	-0.8%	-$17.5K	2.15%	27
2014 Q2	$2.21M	Sell	45,665 -600	-1%	-$29.6K	1.92%	27
2014 Q1	$2.4M	Sell	46,265 -100	-0.2%	-$5.32K	2.25%	26
2013 Q4	$2.46M	Buy	+46,365	New	+$2.36M	2.43%	21

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Pring Turner Capital Group's BMY Position: Q3 2023 in Review

Pring Turner Capital Group sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,440 shares — an estimated $220K sold.

Pring Turner Capital Group first reported a position in BMY in Q4 2013 and held it in 12 quarters. The position peaked at $2.75M in Q2 2015. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Pring Turner Capital Group reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
Pring Turner Capital Group sold 3,440 Bristol-Myers Squibb shares in Q3 2023, an estimated $220K.
Pring Turner Capital Group first reported a position in Bristol-Myers Squibb in Q4 2013 and held it in 12 quarters.
Pring Turner Capital Group's Bristol-Myers Squibb position peaked at $2.75M in Q2 2015.
2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Pring Turner Capital Group's 13F filing for Q3 2023, filed 9 Nov 2023.